Amphastar Pharmaceuticals Depreciation & Amortization 2011-2026 | AMPH

Annual Depreciation & Amortization Amphastar Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
31.6 M	28.2 M	25.2 M	23.8 M	10.2 M	9.03 M	7.06 M	6.05 M	6.42 M	12.2 M	11.3 M	12.5 M	11.2 M	9.66 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
31.6 M	6.05 M	14.6 M

Quarterly Depreciation & Amortization Amphastar Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
14.1 M	14.6 M	7.37 M	-	13.4 M	13.1 M	6.82 M	-	9.62 M	3.06 M	3.4 M	-	3.42 M	3 M	2.74 M	-	2.5 M	2.64 M	2.48 M	-	2.46 M	2.03 M	2.05 M	-	1.7 M	1.66 M	1.64 M	-	10.4 M	6.51 M	3.06 M	-	9.67 M	6.24 M	3.1 M	-	9.01 M	6 M	2.95 M	-	8.52 M	5.63 M	2.77 M	-	9.24 M	6.04 M	2.94 M	-	8.19 M	5.4 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
14.6 M	1.64 M	5.78 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Cabaletta Bio CABA	1.65 M	$ 3.37	3.45 %	$ 339 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.2	4.75 %	$ 5.27 M	Israel
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 334.86	-1.34 %	$ 43.9 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Aligos Therapeutics ALGS	930 K	$ 7.36	-15.79 %	$ 72.8 M	USA
Esperion Therapeutics ESPR	105 K	$ 2.08	1.22 %	$ 432 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Forte Biosciences FBRX	64 K	$ 31.11	-4.04 %	$ 403 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
GT Biopharma GTBP	4 K	$ 0.38	-1.83 %	$ 2.1 M	USA
Harmony Biosciences Holdings HRMY	23.8 M	$ 29.22	-0.24 %	$ 1.68 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
ImmuCell Corporation ICCC	2.78 M	$ 7.64	-1.18 %	$ 69 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	1.27 M	$ 1.54	-1.23 %	$ 396 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.19	1.07 %	$ 448 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 24.26	-3.31 %	$ 3.09 B	USA
Incyte Corporation INCY	93.3 M	$ 97.7	0.01 %	$ 19.1 B	USA
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.48	-0.34 %	$ 394 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands